Repare Therapeutics (RPTX) Competitors $3.35 -0.10 (-2.90%) (As of 10/31/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RPTX vs. BDTX, STOK, NGNE, ORIC, NUVB, QTTB, ALMS, AURA, SLN, and CRVSShould you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include Black Diamond Therapeutics (BDTX), Stoke Therapeutics (STOK), Neurogene (NGNE), ORIC Pharmaceuticals (ORIC), Nuvation Bio (NUVB), Q32 Bio (QTTB), Alumis (ALMS), Aura Biosciences (AURA), Silence Therapeutics (SLN), and Corvus Pharmaceuticals (CRVS). These companies are all part of the "pharmaceutical products" industry. Repare Therapeutics vs. Black Diamond Therapeutics Stoke Therapeutics Neurogene ORIC Pharmaceuticals Nuvation Bio Q32 Bio Alumis Aura Biosciences Silence Therapeutics Corvus Pharmaceuticals Repare Therapeutics (NASDAQ:RPTX) and Black Diamond Therapeutics (NASDAQ:BDTX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations, risk and community ranking. Which has higher valuation & earnings, RPTX or BDTX? Black Diamond Therapeutics has lower revenue, but higher earnings than Repare Therapeutics. Repare Therapeutics is trading at a lower price-to-earnings ratio than Black Diamond Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRepare Therapeutics$68.68M2.07-$93.80M-$1.10-3.05Black Diamond TherapeuticsN/AN/A-$82.44M-$1.50-1.83 Does the MarketBeat Community believe in RPTX or BDTX? Black Diamond Therapeutics received 10 more outperform votes than Repare Therapeutics when rated by MarketBeat users. Likewise, 69.44% of users gave Black Diamond Therapeutics an outperform vote while only 64.52% of users gave Repare Therapeutics an outperform vote. CompanyUnderperformOutperformRepare TherapeuticsOutperform Votes4064.52% Underperform Votes2235.48% Black Diamond TherapeuticsOutperform Votes5069.44% Underperform Votes2230.56% Is RPTX or BDTX more profitable? Black Diamond Therapeutics has a net margin of 0.00% compared to Repare Therapeutics' net margin of -99.76%. Repare Therapeutics' return on equity of -31.11% beat Black Diamond Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Repare Therapeutics-99.76% -31.11% -26.39% Black Diamond Therapeutics N/A -69.08%-51.68% Do analysts rate RPTX or BDTX? Repare Therapeutics currently has a consensus price target of $10.00, indicating a potential upside of 198.51%. Black Diamond Therapeutics has a consensus price target of $15.50, indicating a potential upside of 465.69%. Given Black Diamond Therapeutics' higher probable upside, analysts clearly believe Black Diamond Therapeutics is more favorable than Repare Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Repare Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Black Diamond Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, RPTX or BDTX? Repare Therapeutics has a beta of 0.72, meaning that its share price is 28% less volatile than the S&P 500. Comparatively, Black Diamond Therapeutics has a beta of 2.47, meaning that its share price is 147% more volatile than the S&P 500. Does the media prefer RPTX or BDTX? In the previous week, Repare Therapeutics had 1 more articles in the media than Black Diamond Therapeutics. MarketBeat recorded 3 mentions for Repare Therapeutics and 2 mentions for Black Diamond Therapeutics. Repare Therapeutics' average media sentiment score of 0.67 beat Black Diamond Therapeutics' score of 0.45 indicating that Repare Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repare Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Black Diamond Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in RPTX or BDTX? 85.1% of Repare Therapeutics shares are held by institutional investors. Comparatively, 95.5% of Black Diamond Therapeutics shares are held by institutional investors. 21.6% of Repare Therapeutics shares are held by insiders. Comparatively, 8.9% of Black Diamond Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryRepare Therapeutics and Black Diamond Therapeutics tied by winning 9 of the 18 factors compared between the two stocks. Ad Porter & CompanyBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Get Repare Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPTX vs. The Competition Export to ExcelMetricRepare TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$142.19M$7.12B$5.36B$8.41BDividend YieldN/A8.77%5.22%4.20%P/E Ratio-2.0416.06131.9317.57Price / Sales2.07258.281,440.1578.36Price / CashN/A50.1639.0633.56Price / Book0.675.674.744.57Net Income-$93.80M$151.16M$115.43M$225.42M7 Day Performance-0.59%-1.80%-0.86%-0.61%1 Month Performance-2.62%5.92%3.61%1.50%1 Year Performance-1.47%39.97%38.90%32.94% Repare Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPTXRepare Therapeutics3.1776 of 5 stars$3.35-2.9%$10.00+198.5%+7.1%$142.19M$68.68M-2.04180BDTXBlack Diamond Therapeutics2.1872 of 5 stars$2.92-2.0%$15.50+430.8%+58.6%$164.26MN/A-1.9590Upcoming EarningsShort Interest ↑STOKStoke Therapeutics3.8458 of 5 stars$12.31+3.4%$20.83+69.2%+250.1%$620.76M$15.16M-5.65100Upcoming EarningsPositive NewsNGNENeurogene1.763 of 5 stars$45.93-5.0%$51.00+11.0%N/A$596.17M$925,000.000.0090ORICORIC Pharmaceuticals4.3193 of 5 stars$8.45+3.7%$18.00+113.0%+47.9%$596.06MN/A-4.8380Upcoming EarningsAnalyst ForecastNews CoverageGap UpNUVBNuvation Bio3.8038 of 5 stars$2.35+6.3%$6.40+172.9%+134.9%$584.47MN/A-1.1160Upcoming EarningsQTTBQ32 Bio1.9151 of 5 stars$46.74-7.6%$72.33+54.8%N/A$563.68M$1.16M-2.0339News CoverageALMSAlumisN/A$11.99+0.8%$28.00+133.5%N/A$559.08MN/A0.00N/AAnalyst ForecastAURAAura Biosciences3.8492 of 5 stars$10.98+0.5%$23.00+109.5%+38.7%$543.98MN/A-6.1350Short Interest ↓SLNSilence Therapeutics2.8674 of 5 stars$18.07-0.1%$57.20+216.5%+147.4%$540.84M$31.55M-14.81100CRVSCorvus Pharmaceuticals1.7416 of 5 stars$8.64+4.0%$10.83+25.4%+714.8%$540.44MN/A-19.2030Upcoming EarningsAnalyst DowngradeShort Interest ↑News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies Black Diamond Therapeutics Alternatives Stoke Therapeutics Alternatives Neurogene Alternatives ORIC Pharmaceuticals Alternatives Nuvation Bio Alternatives Q32 Bio Alternatives Alumis Alternatives Aura Biosciences Alternatives Silence Therapeutics Alternatives Corvus Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RPTX) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.